Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation  Health Technology Assessment. 2024;28(18):1-55
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38551218

Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments  Pharmacoeconomics. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38558212

Clinical Outcomes of Rapid Respiratory Virus Testing in Emergency Departments: A Systematic Review and Meta-Analysis  JAMA Internal Medicine. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38436951

Critical Examination of Modeling Approaches Used in Economic Evaluations of First-Line Treatments for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: A Systematic Literature Review  Pharmacoeconomics. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38489077

The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety Assessments  Drug Safety. 2024;47(4):289-299
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38113017

Efficacy, safety, and cost-effectiveness analysis of Cerebrolysin in acute ischemic stroke: A rapid health technology assessment  Medicine (Baltimore). 2024;103(13):e37593
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38552072

HTA community perspectives on the use of patient preference information: lessons learned from a survey with members of HTA bodies  International Journal of Technology Assessment in Health Care. 2024;40(1):e17
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38439624

Incorporating public and wider stakeholder views in the design of health state valuation studies in adults and young people: an undervalued resource?  Expert Review of Pharmacoeconomics & Outcomes Research. 2024:1-4
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38517687

KardiaMobile 6L for measuring QT interval in people having antipsychotic medication to inform early value assessment: a systematic review  Health Technology Assessment. 2024;28(19):1-94
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38551306

Making an organisation for health technology assessment: lessons from India  BMJ Evidence Based Medicine. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38485208

Methods to include environmental impacts in health economic evaluations and health technology assessments: a scoping review  Value in Health. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38462223

Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process  Journal of Pharmacy & Pharmaceutical Sciences. 2024;27:12302
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38481726

Regulatory Issues of Platform Trials: Learnings from EU-PEARL  Clinical Pharmacology and Therapeutics. 2024
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38529786

Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis  Health Technology Assessment. 2024;28(11):1-204
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38512017

SurvInt: a simple tool to obtain precise parametric survival extrapolations  BMC Medical Informatics and Decision Making. 2024;24(1):76
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38486175

Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research  Health Technology Assessment. 2024;28(9):1-176
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38476084

Under the Tech Umbrella: Assessing the Landscape of Telemedicine Innovations (Telemechron Study)  Healthcare (Basel). 2024;12(6)
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38540579